Industrial Genetics

Industrial Genetics is a small private biotechnology and diagnostics company based in Temple, Texas. The company launched proprietary molecular testing services in 2020 to detect SARS-CoV-2 in wastewater and on surfaces, supporting environmental surveillance for schools, healthcare facilities, employers, and other organizations. Available third-party company profiles indicate that it later broadened its positioning toward life sciences business development and consulting services in biotechnology, genetic engineering, and healthcare. Publicly visible information suggests the business is founder-led by David Sprague, Ph.D., and operates as a niche life science services company rather than a therapeutics developer. There is no evidence of a drug development pipeline or clinical-stage therapeutic assets.